# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001641172-25-025274
Filing Date
2025-08-22
Accepted
2025-08-22 17:28:28
Documents
21
Period of Report
2025-08-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 4.01: Changes in Registrant's Certifying Accountant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | form8-k.htm iXBRL | 8-K | 59280
2 | EX-16.1 | ex16-1.htm | EX-16.1 | 957
3 | EX-99.1 | ex99-1.htm | EX-99.1 | 2197
4 | EX-99.2 | ex99-2.htm | EX-99.2 | 9710
5 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 656359
6 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 153909
7 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 13194
8 | GRAPHIC | ex16-1_001.jpg | GRAPHIC | 233790
| Complete submission text file | 0001641172-25-025274.txt |  | 1745913

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL SCHEMA FILE | ptix-20250807.xsd | EX-101.SCH | 3795
10 | XBRL DEFINITION FILE | ptix-20250807_def.xml | EX-101.DEF | 26654
11 | XBRL LABEL FILE | ptix-20250807_lab.xml | EX-101.LAB | 36748
12 | XBRL PRESENTATION FILE | ptix-20250807_pre.xml | EX-101.PRE | 25278
24 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 5769

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12555 | Film No.: 251247277
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)